bpc 157 human studies randomized clinical trial The Stable Gastric Pentadecapeptide Pleiotropic Beneficial Activity and Its Possible Relations with Neurotransmitter Activity BPC-157 as an Investigational Peptide
Description
doi: 10.1016/j.mehy.2020.110043
These relationships have been studied in various autoimmune diseases, including multiple sclerosis (MS), systemic sclerosis (SSc), type 1 diabetes (T1D), Grave's disease (GD), systemic lupus erythematosus (SLE), aplastic anemia (AA), and vitiligo
Drug Discovery Today, 20(1), 122-128
Morning injections are recommended, ideally 30 minutes before breakfast
It is not an approved drug, food, or dietary supplement and is not intended for human or animal consumption
